In this regard, tirzepatide appears to exert remarkable positive effects on glycaemic control and body weight loss in type 2 diabetes mellitus, with benefits well beyond that observed in patients treated with GLP‐1 receptor mimetic therapy alone (Frías, 2020). The gene discussed is GLP1R; the disease is diabetes mellitus.